Molecular farming for sustainable production of clinical‐grade antimicrobial peptides
Plant Biotechnology Journal · 2024-08 · 22 (8) · 2282-2300
DOI: 10.1111/pbi.14344 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Plant Biotechnology Journal, online erschienen am 29.04.2024. Verfasst von Shahid Chaudhary und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Genome Engineering and Synthetic Biology, Division of Biological Sciences, 4700 King Abdullah University of Science and Technology, Th…. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Molecular Farming. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdullah University of Science and Technology.
Abstract (Originalsprache)
Antimicrobial peptides (AMPs) are emerging as next‐generation therapeutics due to their broad‐spectrum activity against drug‐resistant bacterial strains and their ability to eradicate biofilms, modulate immune responses, exert anti‐inflammatory effects and improve disease management. They are produced through solid‐phase peptide synthesis or in bacterial or yeast cells. Molecular farming, i.e. the production of biologics in plants, offers a low‐cost, non‐toxic, scalable and simple alternative platform to produce AMPs at a sustainable cost. In this review, we discuss the advantages of molecular farming for producing clinical‐grade AMPs, advances in expression and purification systems and the cost advantage for industrial‐scale production. We further review how ‘green’ production is filling the sustainability gap, streamlining patent and regulatory approvals and enabling successful clinical translations that demonstrate the future potential of AMPs produced by molecular farming. Finally, we discuss the regulatory challenges that need to be addressed to fully realize the potential of molecular farming‐based AMP production for therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Genome Engineering and Synthetic Biology, Division of Biological Sciences, 4700 King Abdullah University of Science and Technology, Thuwal, Saudi Arabia.
ORCID-Profile: Shahid Chaudhary, Magdy Mahfouz
Förderung
- King Abdullah University of Science and Technology
Zitieren
APA
Chaudhary, S., Ali, Z., & Mahfouz, M. (2024). Molecular farming for sustainable production of clinical‐grade antimicrobial peptides. Plant Biotechnology Journal, 22(8), 2282-2300. https://doi.org/10.1111/pbi.14344
Vancouver
Chaudhary S, Ali Z, Mahfouz M. Molecular farming for sustainable production of clinical‐grade antimicrobial peptides. Plant Biotechnology Journal. 2024;22(8):2282-2300. doi:10.1111/pbi.14344
BibTeX
@article{Chaudhary2024,
author = {Chaudhary, Shahid and Ali, Zahir and Mahfouz, Magdy},
title = {Molecular farming for sustainable production of clinical‐grade antimicrobial peptides},
journal = {Plant Biotechnology Journal},
year = {2024},
volume = {22},
number = {8},
pages = {2282--2300},
doi = {10.1111/pbi.14344}
}
EUVIMED